Am J Psychiatry 162:1171-1178, June 2005
© 2005 American Psychiatric Association
Quality-of-Life Impairment in Depressive and Anxiety Disorders
Mark Hyman Rapaport, M.D.,
Cathryn Clary, M.D.,
Rana Fayyad, Ph.D., and
Jean Endicott, Ph.D.
OBJECTIVE: Previous reports demonstrating quality-of-life impairment in anxiety and affective disorders have relied upon epidemiological samples or relatively small clinical studies. Administration of the same quality-of-life scale, the Quality of Life Enjoyment and Satisfaction Questionnaire, to subjects entering multiple large-scale trials for depression and anxiety disorders allowed us to compare the impact of these disorders on quality of life. METHOD: Baseline Quality of Life Enjoyment and Satisfaction Questionnaire, demographic, and clinical data from 11 treatment trials, including studies of major depressive disorder, chronic/double depression, dysthymic disorder, panic disorder, obsessive-compulsive disorder (OCD), social phobia, premenstrual dysphoric disorder, and posttraumatic stress disorder (PTSD) were analyzed. RESULTS: The proportion of patients with clinically severe impairment (two or more standard deviations below the community norm) in quality of life varied with different diagnoses: major depressive disorder (63%), chronic/double depression (85%), dysthymic disorder (56%), panic disorder (20%), OCD (26%), social phobia (21%), premenstrual dysphoric disorder (31%), and PTSD (59%). Regression analyses conducted for each disorder suggested that illness-specific symptom scales were significantly associated with baseline quality of life but explained only a small to modest proportion of the variance in Quality of Life Enjoyment and Satisfaction Questionnaire scores. CONCLUSIONS: Subjects with affective or anxiety disorders who enter clinical trials have significant quality-of-life impairment, although the degree of dysfunction varies. Diagnostic-specific symptom measures explained only a small proportion of the variance in quality of life, suggesting that an individual’s perception of quality of life is an additional factor that should be part of a complete assessment.
This article has been cited by other articles:
|
|
|
|
 
C. A LeardMann, T. C Smith, B. Smith, T. S Wells, M. A K Ryan, and for the Millennium Cohort Study Team
Baseline self reported functional health and vulnerability to post-traumatic stress disorder after combat deployment: prospective US military cohort study
BMJ,
April 16, 2009;
338(apr16_2):
b1273 - b1273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Bibliography for Major Depressive Disorder and Suicide
Focus,
January 1, 2008;
6(1):
58 - 62.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. G. Almeida Montes, A. O. Hernandez Garcia, and J. Ricardo-Garcell
ADHD Prevalence in Adult Outpatients With Nonpsychotic Psychiatric Illnesses
J Atten Disord,
September 1, 2007;
11(2):
150 - 156.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Kroenke, R. L. Spitzer, J. B.W. Williams, P. O. Monahan, and B. Lowe
Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection
Ann Intern Med,
March 6, 2007;
146(5):
317 - 325.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Stein, A. N. Simmons, J. S. Feinstein, and M. P. Paulus
Increased Amygdala and Insula Activation During Emotion Processing in Anxiety-Prone Subjects
Am J Psychiatry,
February 1, 2007;
164(2):
318 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Stein, C. R. Cantrell, M. C. Sokol, M. T. Eaddy, and M. B. Shah
Antidepressant Adherence and Medical Resource Use Among Managed Care Patients With Anxiety Disorders
Psychiatr Serv,
May 1, 2006;
57(5):
673 - 680.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2005
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
